Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT06355895
- Status
- Recruiting
Conditions
- Upper Abdominal Malignancies
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Standardized high-carbohydrate meal — DIETARY_SUPPLEMENT8 ounces of Ensure® nutritional protein shake or a similar meal
Study Details
Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into estimates of dose-volume distribution within normal liver tissue, as well as affecting day-to-day setup fidelity and organ alignment for treatment. This prospective study will examine how diurnal and fast-fed variations in liver volume affect treatment planning for abdominal SBRT.
Key Dates
- Start date
- May 16, 2024
- Status verified
- Jun 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 17 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: High Carbohydrate Diet1. First scan: after an overnight fast of at least 8 hours using standard radiation oncology CT scan with contrast for treatment planning. 2. Standardized high-carb meal such as 8 ounces of Ensure® nutritional protein shake or a similar meal, immediately following first scan and consumed within 15 minutes. 3. Second scan: within 1 hour of ingestion of the high-carb meal using similar settings to those used in the first scan except for contrast use. 4. Third CT scan at least 4 hours (but no more than 5 hours) after ingestion of high-carb diet on the same day utilizing same set up used in first scan with exception for the use of contrast.
Primary Outcome Measure
Diurnal Difference in Liver Volumes [ Time Frame: At baseline and at 4 hours post intervention ]
Central Contacts
- Samantha Demko, BSN412-623-1400
- Brieanna Marino, MS412-647-8258
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Samantha Demko Brieanna Marino Susannah Ellsworth, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By research site